<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-8PS5NYAN</identifier><date>2024</date><creator>Kodrič, Ana</creator><creator>Kos, Mitja</creator><relation>documents/doc/8/URN_NBN_SI_doc-8PS5NYAN_001.pdf</relation><relation>documents/doc/8/URN_NBN_SI_doc-8PS5NYAN_001.txt</relation><format format_type="issue">3</format><format format_type="volume">75</format><format format_type="type">article</format><format format_type="extent">str. 213-219</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">203842819</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-8PS5NYAN</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Klinična praksa</subject><subject language_type_id="slv">priporočila</subject><subject language_type_id="slv">proces oblikovanja</subject><subject language_type_id="slv">slovenske smernice</subject><title>Slovenske klinične smernice in priporočila</title><title>Slovenian clinical guidelines and recommendations</title></Record>